Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining COVID-19 Infection Severity on Presentation to Hospital: a Multicentre Prospective Study

NCT05677789 is registered in ClinicalTrials.gov with Fuzhou General Hospital as lead sponsor.

NCT NCT05677789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining COVID-19 Infection Severity on Presentation to Hospital: a Multicentre Prospective Study
Lead sponsor
Fuzhou General Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 4, 2023
Completion date
December 31, 2023
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, death, assisted, infections, morality